Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
Titel:
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone
Auteur:
Gnant, M. Filipits, M. Greil, R. Stoeger, H. Rudas, M. Bago-Horvath, Z. Mlineritsch, B. Kwasny, W. Knauer, M. Singer, C. Jakesz, R. Dubsky, P. Fitzal, F. Bartsch, R. Steger, G. Balic, M. Ressler, S. Cowens, J.W. Storhoff, J. Ferree, S. Schaper, C. Liu, S. Fesl, C. Nielsen, T.O.